Sanara Historical Income Statement
| SMTI Stock | USD 37.70 0.38 1.02% |
Historical analysis of Sanara Medtech income statement accounts such as Other Operating Expenses of 72.7 M, Cost Of Revenue of 8.2 M, Total Operating Expenses of 64.2 M or Selling General Administrative of 57.5 M can show how well Sanara Medtech performed in making a profits. Evaluating Sanara Medtech income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Sanara Medtech's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Sanara Medtech latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Sanara Medtech is a good buy for the upcoming year.
Sanara |
About Sanara Income Statement Analysis
Sanara Medtech Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Sanara Medtech shareholders. The income statement also shows Sanara investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Sanara Medtech Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts Sanara Medtech generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Sanara Medtech minus its cost of goods sold. It is profit before Sanara Medtech operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Sanara Medtech. It is also known as Sanara Medtech overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Cost Of Revenue
Cost of Revenue is found on Sanara Medtech income statement and represents the costs associated with goods and services Sanara Medtech provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Most accounts from Sanara Medtech's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Sanara Medtech current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sanara Medtech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Sanara Stock please use our How to Invest in Sanara Medtech guide.As of now, Sanara Medtech's Gross Profit is increasing as compared to previous years. The Sanara Medtech's current Other Operating Expenses is estimated to increase to about 72.7 M, while Operating Income is projected to decrease to (4.4 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Total Revenue | 24.1M | 45.8M | 65.0M | 68.2M | Interest Expense | 711.0 | 284.7K | 475.8K | 499.6K |
Sanara Medtech income statement Correlations
Click cells to compare fundamentals
Sanara Medtech Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Sanara Medtech income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 130.1K | 409.0K | 771.9K | 2.6M | 3.7M | 3.9M | |
| Interest Expense | 105.9K | 11.5K | 711.0 | 284.7K | 475.8K | 499.6K | |
| Total Revenue | 11.8M | 15.6M | 24.1M | 45.8M | 65.0M | 68.2M | |
| Gross Profit | 10.6M | 14.0M | 21.8M | 39.5M | 57.1M | 60.0M | |
| Other Operating Expenses | 14.4M | 20.6M | 31.5M | 58.1M | 69.2M | 72.7M | |
| Operating Income | (2.6M) | (5.0M) | (7.4M) | (12.2M) | (4.2M) | (4.4M) | |
| Ebit | (2.6M) | (4.4M) | (8.0M) | (14.5M) | (4.0M) | (4.2M) | |
| Ebitda | (2.5M) | (4.0M) | (7.2M) | (11.9M) | (289.1K) | (303.6K) | |
| Cost Of Revenue | 1.2M | 1.6M | 2.3M | 6.4M | 7.9M | 8.2M | |
| Total Operating Expenses | 13.2M | 19.0M | 29.2M | 51.7M | 61.1M | 64.2M | |
| Income Before Tax | (2.8M) | (4.4M) | (8.0M) | (13.9M) | (4.4M) | (4.7M) | |
| Total Other Income Expense Net | (205.7K) | 589.5K | (617.6K) | (1.4M) | (224.7K) | (236.0K) | |
| Net Income | (2.9M) | (4.4M) | (7.3M) | (8.1M) | (4.3M) | (4.5M) | |
| Income Tax Expense | 94.4K | (62.4K) | (688.1K) | (5.8M) | (136.7K) | (129.9K) | |
| Selling General Administrative | 13.1M | 18.7M | 28.1M | 46.0M | 54.8M | 57.5M | |
| Net Income From Continuing Ops | (2.8M) | (4.4M) | (8.0M) | (8.1M) | (8.3M) | (7.9M) | |
| Net Income Applicable To Common Shares | (2.8M) | (4.4M) | (7.9M) | (7.9M) | (7.1M) | (6.8M) | |
| Net Interest Income | (105.9K) | (11.5K) | (711.0) | (284.7K) | (473.0K) | (449.4K) | |
| Reconciled Depreciation | 120.0K | 291.4K | 597.0K | 2.4M | 3.4M | 3.6M |
Currently Active Assets on Macroaxis
When determining whether Sanara Medtech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sanara Medtech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sanara Medtech Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sanara Medtech Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sanara Medtech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Sanara Stock please use our How to Invest in Sanara Medtech guide.You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sanara Medtech. If investors know Sanara will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sanara Medtech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.99) | Revenue Per Share 9.241 | Quarterly Revenue Growth 0.352 | Return On Assets (0.05) | Return On Equity (0.20) |
The market value of Sanara Medtech is measured differently than its book value, which is the value of Sanara that is recorded on the company's balance sheet. Investors also form their own opinion of Sanara Medtech's value that differs from its market value or its book value, called intrinsic value, which is Sanara Medtech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sanara Medtech's market value can be influenced by many factors that don't directly affect Sanara Medtech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sanara Medtech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sanara Medtech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sanara Medtech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.